Ascend Wellness Holdings, Inc. (AAWH) stock
AAWHOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
$0.39−0.00 (-0.73%)
Close on Oct 19, 2026Market cap $79.60MP/E –Yield –
Ascend Wellness revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Ascend Wellness's revenue for the twelve months ending Jun 30, 2026 was $488.33M, down 8.4% year over year. For fiscal 2025 it was $500.58M, down 10.9% from the year before. The highest annual figure on record is $561.60M in fiscal 2024.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $500.58M | -10.9% |
| FY2024 | Dec 31, 2024 | $561.60M | +8.3% |
| FY2023 | Dec 31, 2023 | $518.59M | +27.8% |
| FY2022 | Dec 31, 2022 | $405.93M | +22.1% |
| FY2021 | Dec 31, 2021 | $332.38M | +131.3% |
| FY2020 | Dec 31, 2020 | $143.73M | +1094.6% |
| FY2019 | Dec 31, 2019 | $12.03M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $126.12M | -0.9% |
| Q1 FY2026 | Mar 31, 2026 | $116.93M | -8.6% |
| Q4 FY2025 | Dec 31, 2025 | $120.55M | -11.4% |
| Q3 FY2025 | Sep 30, 2025 | $124.73M | -11.9% |
| Q2 FY2025 | Jun 30, 2025 | $127.30M | -10.1% |
| Q1 FY2025 | Mar 31, 2025 | $128.00M | -10.1% |
| Q4 FY2024 | Dec 31, 2024 | $136.01M | -3.0% |
| Q3 FY2024 | Sep 30, 2024 | $141.65M | +0.3% |
| Q2 FY2024 | Jun 30, 2024 | $141.54M | +15.1% |
| Q1 FY2024 | Mar 31, 2024 | $142.41M | +24.7% |
| Q4 FY2023 | Dec 31, 2023 | $140.16M | +25.0% |
| Q3 FY2023 | Sep 30, 2023 | $141.27M | +27.0% |
| Q2 FY2023 | Jun 30, 2023 | $122.99M | +26.1% |
| Q1 FY2023 | Mar 31, 2023 | $114.18M | +34.2% |
| Q4 FY2022 | Dec 31, 2022 | $112.10M | +26.7% |
| Q3 FY2022 | Sep 30, 2022 | $111.24M | +17.9% |
| Q2 FY2022 | Jun 30, 2022 | $97.50M | +17.0% |
| Q1 FY2022 | Mar 31, 2022 | $85.09M | +28.7% |
| Q4 FY2021 | Dec 31, 2021 | $88.50M | +63.0% |
| Q3 FY2021 | Sep 30, 2021 | $94.38M | +127.6% |
| Q2 FY2021 | Jun 30, 2021 | $83.37M | +228.4% |
| Q1 FY2021 | Mar 31, 2021 | $66.14M | +192.7% |
| Q4 FY2020 | Dec 31, 2020 | $54.28M | – |
| Q3 FY2020 | Sep 30, 2020 | $41.47M | – |
| Q2 FY2020 | Jun 30, 2020 | $25.38M | – |
| Q1 FY2020 | Mar 31, 2020 | $22.59M | – |
See a number that looks wrong?